The IPOX® Week, July 20, 2020

  • IPOX Indexes trade mixed. IPOX 100 Europe (ETF: FPXE) closes week at highest level on record.
  • IPOX 100 U.S. (ETF: FPX) falls -1.00% to +9.10% YTD. IPOX International (ETF: FPXI) declines -1.55% to +33.46% YTD. IPOX 100 Europe (ETF: FPXE) gains +2.16% to +15.25% YTD.
  • Unicorn Jamf (JAMF US) lined up.

IPOX Indexes trade mixed during U.S. options expiration week. European IPOs a great place to be: Diversified IPOX 100 Europe (ETF: FPXE) closes week at highest level on record. The IPOX Indexes traded mixed last week. While profit taking in high-beta exposure amid stable yields and declining equity risk (VIX: -5.90%) after the big-run ahead of earnings pressured the IPOX China (CNI), IPOX 100 U.S. (ETF: FPX) and IPOX International (ETF: FPXI), the broad-based, diversified IPOX 100 Europe (ETF: FPXE) closed out the week at a fresh all-time high. Here, big gains in European-domiciled specialty firms across the market cap and industry spectrum propelled the strategy by +2.16% to +15.25% YTD, a fresh all-time high and a massive +2311 bps. YTD ahead of the STOXX Europe 50 (SX5L). The IPOX 100 Europe (ETF: FPXE) provides access to the performance of 100 large and well-performing European domiciled New Listings trading across Europe and the U.S. by applying a portfolio technology pioneered in the $1.4 billion U.S. (ETF: FPX) and $0.2 billion International (ETF: FPXI) IPOX counterparts, respectively. Amid its focus on faster growing economic sectors and regions (e.g. Nordic), the portfolio currently also displays little overlap with the conventional benchmarks.

European IPO Investing with the “FPXE” ETF since launch:

In the U.S., the IPOX 100 U.S. (ETF: FPX) declined -1.00% to +9.10% YTD last week, better than when compared to the NASDAQ 100 (NDX: -1.76%) but lagging the S&P 500 (SPX), benchmark for U.S. stocks. Profit taking in global technology exposure contributed to the weak showing, including infrastructure software maker Fastly (FSLY US: -17.82%), security software firm Crowdstrike (CRWD US: -13.05%) or video conferencing platform operator Zoom Video (ZM US: -10.63%), while Marcus Lemonis’, IL-based recreational vehicle specialist Camping World Holdings (CWH US: +16.14%) rose to a fresh weekly high. We note more pending IPO M&A action with large-pharma, French drug maker Sanofi (SAN FP: +6.08%) mulling U.S. Biotech Targets including IPOX 100 U.S. (ETF: FPX) holding $2.8 billion Principia Biopharma (PRNB US: +32.70%).

Select IPOX® Indexes Price Returns (%) Last Week 2019 2020 YTD
IPOX® Indexes: Global/International
IPOX® Global (IPGL50) (USD) -1.85 27.93 29.23
IPOX® International (IPXI)* (USD) (ETF: FPXI) -1.55 31.37 33.46
IPOX® Indexes: United States
IPOX® 100 U.S. (IPXO)* (USD) (ETF: FPX) -1.00 29.60 9.10
IPOX® Indexes: Europe/Nordic
IPOX® 30 Europe (IXTE) (EUR) 1.32 34.55 24.55
IPOX® Nordic (IPND) 1.92 38.52 33.18
IPOX® 100 Europe (IPOE)* (USD) 2.16 30.97 15.25
IPOX® Indexes: Asia-Pacific/China
IPOX® Asia-Pacific (IPTA) (USD) -0.14 4.41 16.59
IPOX® China (CNI) (USD) -5.41 26.31 36.51
IPOX® Japan (IPJP)** (JPY) 0.78 37.91 1.47

* Basis for ETFs: FPX US, FPX LN, FPXE US, FPXU FP, FPXI US, TCIP110 IT and CME-traded e-mini IPOX® 100 U.S. Futures (IPOM0). Source: Bloomberg L.P. & Refinitiv/Thomson Reuters. For IPOX Alternative Strategies Returns, please contact [email protected]

IPOX-linked ETFs (FPX, FPXI, FPXE) Movers (Last Week in %):
LIFCO AB 10.10 XP INC -9.40

IPO Deal-flow Review and Outlook: Market set to cool with PE-backed software unicorn Jamf lines up. At least 19 IPOs IPO’d across the global regions last week, with the average (median) equally-weighted deal adding +44.34% (+11.33%) based on the difference between the final offering price and their respective Friday’s close. Fintech unicorn nCino (NCNO: +138.71%), SoftBank-backed biotech Relay Therap. (RLAY US: +119.90%) and cellular therapy firm Berkeley Lights (BLI US: +197.50%) more than doubled, while Hong Kong’s largest IPO YTD, China Bohai Bank (9668 HK: -1.87%) slipped. We also note the surge in Toronto-traded legal software developer Dye & Durham (DND CN: +97.33%). After busy week, the IPO activity is set to slow with enterprise software management unicorn Jamf (JAMF US) lined up. Other IPO news include: 1) PE-backed firms lined up include Shopify rival BigCommerce, Chicago-based primary care operator Oak Street Health and medical cost management firm MultiPlan (reverse IPO) 2) SoftBank weighs an IPO for its $40B British chip designer Arm 3) EV makers to ride on Tesla’s winning track with Fisker (in reverse IPO with Apollo-backed SPAC) and Chinese food delivery giant Meituan-backed Li Auto filing for an IPO 4) Brazil state-owned lender Caixa Seguridade resumes going public plan 5) Australian cash back site Cashrewards set to list 6) Airbnb back on track with IPO plan.

Lightspeed Financial Services Group LLC is not affiliated with these third-party market commentators/educators or service providers. Data, information, and material (“content”) are provided for informational and educational purposes only. This content neither is, nor should be construed as an offer, solicitation, or recommendation to buy or sell any securities or contracts. Any investment decisions made by the user through the use of such content is solely based on the users independent analysis taking into consideration your financial circumstances, investment objectives, and risk tolerance. Lightspeed Financial Services Group LLC does not endorse, offer nor recommend any of the services or commentary provided by any of the market commentators/educators or service providers and any information used to execute any trading strategies are solely based on the independent analysis of the user.

You may also be interested in...

The IPOX® Week, October 25th, 2021
Read More
Bank Stocks Kick Of Q3 Earnings Season With A Bang
Read More
The IPOX® Week, October 18th, 2021
Read More
4 Bad Habits That Stock Traders Should Break
Read More

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.